High-density electroanatomic activation mapping to guide slow pathway modification in patients with persistent left
Dimitrios Gerontitis1, Michael T B Pope1, Mahmoud Elmowafy1
1University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
Heart Rhythm
|April 5, 2023
Summary
This study introduces a new method for slow pathway (SP) mapping and ablation in patients with persistent left superior vena cava (PLSVC). The technique uses 3D electroanatomic mapping (EAM) to precisely locate ablation targets, ensuring safety and effectiveness.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Imaging
Background:
- Slow pathway (SP) mapping and modification are challenging in patients with persistent left superior vena cava (PLSVC) due to anatomical variations.
- Limited studies exist on detailed 3D electroanatomic mapping (EAM) for guiding ablation in these complex cases.
Purpose of the Study:
- To describe a novel technique for SP mapping and ablation in sinus rhythm using 3D EAM.
- To validate this technique in patients with PLSVC after successful application in patients with normal coronary sinus (CS) anatomy.
Main Methods:
- Utilized high-resolution, ultra-high-density local activation timing mapping in sinus rhythm.
- Included seven patients with PLSVC and dual atrioventricular (AV) nodal physiology, and 21 control patients.
- Focused mapping on the right atrial septum and proximal CS.
Main Results:
- SP ablation targets were identified by latest activation times and specific electrogram characteristics in the right atrial septum.
- In PLSVC patients, targets were consistently found near the midanterior CS ostium.
- Successful SP modification was achieved with radiofrequency or cryoablation without complications.
Conclusions:
- High-resolution activation mapping in sinus rhythm aids in precise localization of SP ablation targets.
- This approach facilitates safe and effective SP ablation in patients with PLSVC.
- The described technique offers a valuable tool for managing complex AV nodal reentrant tachycardias in this patient population.


